ERBB2 and breast neoplasm: In addition, breast tumors with HER2 overexpression had higher proliferation and metastasis with the presence of prolactin stimulating tyrosine phosphorylation of HER2 and activating mitogen-activated protein kinase (MAPK) signaling[45].